NASDAQ:CRIS
$0.543
(
4.42%
)
Friday, 24th Mar 2023
Curis Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $0.500 | $0.750 | Friday, 24th Mar 2023 CRIS stock ended at $0.543. This is 4.42% more than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 6.03% from a day low at $0.514 to a day high of $0.545. |
90 days | $0.470 | $0.799 | |
52 weeks | $0.470 | $2.63 |
Historical Curis prices
Date | Open | High | Low | Close | Volume |
2023-03-24 | $0.540 | $0.545 | $0.514 | $0.543 | 244 995 |
2023-03-23 | $0.560 | $0.560 | $0.513 | $0.520 | 318 968 |
2023-03-22 | $0.536 | $0.560 | $0.536 | $0.550 | 275 976 |
2023-03-21 | $0.540 | $0.540 | $0.500 | $0.506 | 542 959 |
2023-03-20 | $0.550 | $0.550 | $0.510 | $0.511 | 290 977 |
2023-03-17 | $0.560 | $0.561 | $0.520 | $0.540 | 348 487 |
2023-03-16 | $0.520 | $0.588 | $0.500 | $0.561 | 428 000 |
2023-03-15 | $0.580 | $0.620 | $0.520 | $0.528 | 485 170 |
2023-03-14 | $0.585 | $0.620 | $0.560 | $0.560 | 596 752 |
2023-03-13 | $0.640 | $0.660 | $0.556 | $0.576 | 1 135 943 |
2023-03-10 | $0.670 | $0.681 | $0.620 | $0.629 | 527 099 |
2023-03-09 | $0.669 | $0.707 | $0.657 | $0.679 | 488 418 |
2023-03-08 | $0.680 | $0.694 | $0.650 | $0.663 | 249 179 |
2023-03-07 | $0.690 | $0.713 | $0.680 | $0.694 | 242 160 |
2023-03-06 | $0.687 | $0.710 | $0.687 | $0.710 | 275 449 |
2023-03-03 | $0.628 | $0.750 | $0.628 | $0.690 | 908 399 |
2023-03-02 | $0.634 | $0.640 | $0.610 | $0.637 | 464 451 |
2023-03-01 | $0.620 | $0.650 | $0.615 | $0.630 | 434 354 |
2023-02-28 | $0.628 | $0.637 | $0.611 | $0.622 | 247 866 |
2023-02-27 | $0.618 | $0.660 | $0.603 | $0.629 | 298 436 |
2023-02-24 | $0.630 | $0.641 | $0.610 | $0.616 | 192 044 |
2023-02-23 | $0.660 | $0.665 | $0.630 | $0.630 | 202 944 |
2023-02-22 | $0.646 | $0.670 | $0.617 | $0.646 | 310 256 |
2023-02-21 | $0.690 | $0.690 | $0.621 | $0.634 | 347 449 |
2023-02-17 | $0.668 | $0.694 | $0.650 | $0.685 | 293 346 |
2023-02-16 | $0.686 | $0.700 | $0.660 | $0.661 | 502 080 |
2023-02-15 | $0.704 | $0.715 | $0.676 | $0.697 | 346 307 |
2023-02-14 | $0.749 | $0.749 | $0.700 | $0.715 | 221 070 |
2023-02-13 | $0.738 | $0.738 | $0.710 | $0.729 | 153 610 |
2023-02-10 | $0.703 | $0.738 | $0.703 | $0.726 | 290 877 |
2023-02-09 | $0.764 | $0.767 | $0.710 | $0.722 | 353 253 |
2023-02-08 | $0.760 | $0.780 | $0.750 | $0.757 | 237 820 |
2023-02-07 | $0.780 | $0.789 | $0.754 | $0.761 | 340 385 |
2023-02-06 | $0.760 | $0.780 | $0.750 | $0.761 | 369 779 |
2023-02-03 | $0.778 | $0.799 | $0.769 | $0.780 | 479 363 |
2023-02-02 | $0.730 | $0.790 | $0.730 | $0.778 | 576 930 |
2023-02-01 | $0.750 | $0.760 | $0.709 | $0.725 | 658 167 |
2023-01-31 | $0.772 | $0.789 | $0.730 | $0.733 | 589 955 |
2023-01-30 | $0.780 | $0.790 | $0.760 | $0.767 | 256 676 |
2023-01-27 | $0.750 | $0.790 | $0.746 | $0.780 | 1 128 770 |
2023-01-26 | $0.775 | $0.780 | $0.740 | $0.755 | 356 627 |
2023-01-25 | $0.750 | $0.770 | $0.734 | $0.760 | 624 695 |
2023-01-24 | $0.790 | $0.795 | $0.721 | $0.749 | 765 538 |
2023-01-23 | $0.717 | $0.770 | $0.681 | $0.751 | 1 025 735 |
2023-01-20 | $0.720 | $0.737 | $0.680 | $0.700 | 611 909 |
2023-01-19 | $0.730 | $0.750 | $0.680 | $0.720 | 308 300 |
2023-01-18 | $0.717 | $0.797 | $0.717 | $0.720 | 975 336 |
2023-01-17 | $0.750 | $0.750 | $0.703 | $0.713 | 466 312 |
2023-01-13 | $0.740 | $0.799 | $0.710 | $0.730 | 763 855 |
2023-01-12 | $0.690 | $0.770 | $0.680 | $0.750 | 1 123 100 |
About Curis
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.